Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues	$ 63,057	$ 5,287	$ 159,234	$ 34,759
Cost of revenues	54,590	17,738	142,074	43,337
Gross profit	8,467	(12,451)	17,160	(8,578)
Operating expenses:
Research and development, net	17,508	14,189	50,150	29,797
Selling, general and administrative	22,961	25,655	64,991	39,347
Total operating expenses	40,469	39,844	115,141	69,144
Operating loss	(32,002)	(52,295)	(97,981)	(77,722)
Other income (expense):
Interest expense, net	(1,486)	(2,977)	(6,907)	(3,377)
Gain (loss) on foreign exchange	(51)	16	(3,947)	(389)
Change in fair value of liability classified warrants	0	(33,947)	13,482	(39,424)
Other income (expense), net	622	(450)	625	(583)
Total other income (expense), net	(915)	(37,358)	3,253	(43,773)
Loss before income taxes	(32,917)	(89,653)	(94,728)	(121,495)
Benefit (provision) for income taxes	(1,693)	1,684	(4,008)	979
Net loss	(34,610)	(87,969)	(98,736)	(120,516)
Other comprehensive income (loss), net of tax:
Foreign currency translation income (loss)	(4,655)	(1,008)	(4,809)	66
Unrealized loss on available-for-sale marketable securities	(855)	0	(855)	0
Comprehensive loss	$ (40,120)	$ (88,977)	$ (104,400)	$ (120,450)
Net loss per share attributable to Rocket Lab USA, Inc.:
Net loss per share attributable to common stockholders-basic	$ (0.07)	$ (0.39)	$ (0.21)	$ (0.93)
Net loss per share attributable to common stockholders- diluted	$ (0.07)	$ (0.39)	$ (0.21)	$ (0.93)
Weighted-average common shares outstanding:
Weighted average common shares outstanding-basic	469,768,797	228,266,647	463,709,955	129,232,016
Weighted average common shares outstanding, diluted	469,768,797	228,266,647	463,709,955	129,232,016